Document is current
Any future updates will be listed below
-
Authors
Kotecha, Rupesh
Tonse, Raees
Menendez, Miguel A. Ramirez
Williams, Andre
Diaz, Zuanel
Tom, Martin C.
Hall, Matthew D.
Mehta, Minesh P.
Alvarez, Reinier
Siomin, Vitaly
Odia, Yazmin
Ahluwalia, Manmeet S.
McDermott, Michael W.
- License Information
-
More Information
Article History
Received: 12 October 2021
Accepted: 23 February 2022
First Online: 16 March 2022
Competing interests
: R. Kotecha: Honoraria from Accuray Inc., Elekta AB, Viewray Inc., Novocure Inc., Elsevier Inc., Brainlab. Institutional research funding from Medtronic Inc., Blue Earth Diagnostics Ltd., Novocure Inc., GT Medical Technologies, Astrazeneca, Exelixis, Viewray Inc., Brainlab. R. Tonse: None. M. Menendez: None. A. Williams: None. Z. Diaz: None. M. Tom: Honoraria from Viewray Inc. Institutional research funding from Blue Earth Diagnostics Ltd. M. Hall: Honorarium from Accuray, Inc. Proton Collaborative Group Executive Committee Institutional Representative and Voting Member, Miami Cancer Institute (unpaid). Grant Funding: Live Like Bella Pediatric Cancer Research Initiative, Florida Department of Health Grant 8LA04. M.P. Mehta: Consulting for Karyopharm, Sapience, Xoft, Zap, Mevion. Board of Directors: Oncoceutics; Stock: Chimerix. R. Alvarez: None. V. Siomin: None. M. S. Ahluwalia: Receipt of grants/research supports: Astrazeneca, BMS, Bayer, Incyte, Pharmacyclics, Novocure, Mimivax, Merck. Receipt of honoraria or consultation fees: Bayer, Novocure, Kiyatec, Insightec, GSK, Xoft, Nuvation, Cellularity, SDP Oncology, Apollomics, Prelude, Janssen. Stock shareholder: Doctible, Mimivax, Cytodyn, MedInnovate Advisors LLC. Y.Odia: Institutional research funding: BMS, Novocure Inc., DSMC: GammaTile, Actuate, Oncoceutics/Chimerix. Advisory Board: Novocure Inc, Abbvie. Consulting: Abbvie. M. W. McDermott: Consulting for Deinde Medical and Stryker Corporation.
